Frontiers
US$ 23.30
glp 1 nejm GLP-1 Receptor Agonists Semaglutide in Patients with Obesity-Related
Description
GLP1-s work best as long-term medications
Research shows that prebiotics can help increase GLP-1 secretion
This analytical review critically examines the evidence surrounding GLP-1 agonists efficacy, safety, and real-world implications for obesity treatment in individuals without diabetes
Concomitantly, body weight-favorable therapeutic approaches are being dictated by the obesity pandemic, which extends to all diabetes subpopulations
Finally, a weight loss approach that works with your biology.
